Advertisement

Organisation › Details
Taiho Ventures LLC
Taiho Ventures, LLC is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy and immunology, and urology. With $300M under management, Taiho Ventures is actively investing in early-stage private companies strategically relevant to Taiho Pharmaceutical. The firm considers company creation, spinouts and the option-type of investments as well as pure equity investments. *
![]() |
Start | 2016-04-15 established |
Group | Otsuka (Group) | |
![]() |
Industry | venture capital |
Industry 2 | BIOTECH | |
![]() |
Person | Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures) |
![]() |
Region | Menlo Park, CA |
Country | United States (USA) | |
Street | 2420 Sand Hill Road Suite 203 | |
City | 94025-6940 Menlo Park, CA | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 300,000,000 (capital under management (2021) 2021-04-22) | |
* Document for »About Section«: Anavo Therapeutics B.V.. (4/22/21). "Press Release: Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators". Leiden. | ||
Record changed: 2025-01-19 |
Advertisement

More documents for Otsuka (Group)
- [1] Ionis Pharmaceuticals, Inc.. (12/18/23). "Press Release: Ionis Announces European Licensing Agreement with Otsuka for Donidalorsen in Hereditary Angioedema". Carlsbad, CA....
- [2] Cellvie Inc.. (2/6/23). "Press Release: Cellvie Closes $5.5M of Additional Funding to Accelerate the Development of Therapeutic Mitochondria Transplantation". Zürich & Houston, TX....
- [3] ERS Genomics Ltd.. (3/3/21). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical". Dublin....
- [4] Beckley Psytech Ltd.. (2/23/21). "Press Release: Beckley Psytech Appoints Ex-pharma CEO as Chief Operating Officer"....
- [5] Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA....
- [6] Bicycle Therapeutics plc. (10/29/19). "Press Release: Bicycle Therapeutics Announces Appointment of Nigel Crockett, Ph.D., as Chief Business Officer". Cambridge & Boston, MA....
- [7] Healx Ltd.. (7/11/19). "Press Release: Dr Neil Thompson Appointed CSO of Healx to Spearhead Drug Discovery Expansion"....
- [8] LeadXPro AG. (6/3/19). "Press Release: LeadXPro and Astex Enter Strategic Partnership on Membrane Protein Strcuture Research". Cambridge & Villigen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top